Named on one round in the feed.
Since 2018-06-06
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Astrocyte Pharmaceuticals Inc. A clinical-stage biotechnology company developing first-in-class cerebroprotective therapies for concussion, traumatic brain injury (TBI) and stroke | Pre-A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $2.3M | 2018-06-06 | [ LEAD ] |